Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Current medicinal chemistry
Numerous collaborative initiatives with the final aim of drug repurposing were objects of debate, among wich: The AZ Open Innovation program, the NIH National Center for Advancing Translational Sciences (NCATS) program: Discovering New Therapeutic Uses for Existing Molecules, the Medical Research Council (MRC) and AstraZeneca (AZ) Mechanisms of Human Disease Initiative, The Clinical and Translational Science Award (CTSA) Pharmaceutical Assets Portal, European College of Neuropsychopharmacology (ECNP) Medicines Chest Program, Pfizers SpringWorks Program, the AstraZeneca/National Research Program for Biopharmaceuticals (NRPB) partnership in Taiwan, the Roche/Broad Institute Collaboration, and the Drugs for Neglected Diseases Initiative (DNDI), the Clinical Development Partnerships Initiative (Krishnamurthy et al., 2022)
Insulin-like Growth Factor 1 Inhibits Apoptosis Using the Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase Pathways
Note: I do not treat KP, please see my colleagues at Clinic Cutis
doi: 10.1042/BSR20211696 55
The safe alternative options include tirzepatide (a dual agonist), Rybelsus (an oral pill), or classic appetite suppressants
US$ 29.84
US$ 22.02
US$ 27.10
US$ 22.22
US$ 26.98
US$ 21.63
